SCHEMBL4639184

SCHEMBL4639184

NCC(c1ccccc1)(c1cc(F)cc(C(F)(F)F)c1)c1ccc(Cl)cn1

nearest known ligand 0.52

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ CETP P11597 20/20 0.52
▸ KCNH2 Q12809 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10202789 0.89 CETP (0.47) CETPKCNH2
SCHEMBL4640202 0.87 CETP (0.43) CETP
SCHEMBL4717108 0.83 CETP (0.50) CETPKCNH2
SCHEMBL4639381 0.83 KIF11 (0.44) CETPKCNH2
SCHEMBL4639727 0.80 CETP (0.49) CETPKCNH2
SCHEMBL4639127 0.80 CETP (0.53) CETPKCNH2
SCHEMBL4640350 0.79 CETP (0.51) CETPKCNH2
SCHEMBL4640200 0.79 CETP (0.49) CETPKCNH2
SCHEMBL4640356 0.79 NOS3 (0.39) CETP
SCHEMBL4720163 0.78 CETP (0.65) CETP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1951673-A2 HETEROCYCLIC CETP INHIBITORS Bristol-Myers Squibb Company (US) 2008-08-06 — — EP disclosed
EP-1951690-A1 HETEROCYCLIC CETP INHIBITORS Brystol-Myers Squibb Company (US) 2008-08-06 — — EP disclosed
WO-2007062314-A2 HETEROCYCLIC CETP INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2007-05-31 — — WO disclosed
WO-2007062342-A1 HETEROCYCLIC CETP INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2007-05-31 — — WO disclosed
Send feedback